"Our SightMD eye care center in Babylon, New York is led by the caring and compassionate hands of Samuel Baharestani and his team. Services provided include LASIK surgery, cataract surgery, pediatric ophthalmology, general ophthalmology, and ocular plastic surgery. Our mission is to provide the highest quality ophthalmology services in a setting that is attractive to patients of all ethnic and educational backgrounds, that is cost-effective, and meets the needs of our community."

During the past decade, SightMD conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SightMD" #1 collaborator was "Ocular Therapeutix, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SightMD" are "Corneal Ulcer" (2 trials), "Keratitis" (2 trials), "Cataract" (1 trials), "Cataract Senile" (1 trials) and "Collagen Crosslinking" (1 trials). Many other conditions were trialed in "SightMD" in a lesser frequency.

Most popular intervention types in "SightMD" are "Other" (3 trials), "Combination Product" (2 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dextenza" (1 trials), "PXL Platinum 330 system + Riboflavin 0.25% TE Solution" (1 trials), "Prednisolone Acetate" (1 trials), "Sham CXL + Artificial Tears" (1 trials) and "Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "SightMD" are 5 trials for "All" genders.

Currently, there are NaN active trials in "SightMD". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in SightMD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SightMD, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".